SciSparc (SPRC) Announces Successful Final Phase IIa Results, Meeting End Points of its Phase IIa Alzheimer Disease Patients with Agitation Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Topline results using the Company s SCI-110 met the trial’s primary and secondary end points, demonstrating high safety profile and reduced agitationTel-Aviv, June 02, 2023 SciSparc Ltd. ,. | June 2, 2023
Phototherapy is a safe, effective, noninvasive, inexpensive way of boosting cognition in dementia in new research that suggests it may be "one of the most promising" interventions for improving core symptoms of the disease.